SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (21866)5/11/1999 2:03:00 PM
From: Joe Fang  Read Replies (1) | Respond to of 23519
 
Vlad, TAKE OVER THEIR IR DEPARTMENT !



To: VLAD who wrote (21866)5/11/1999 3:28:00 PM
From: KHS  Respond to of 23519
 
VLAD, I am just about convinced VVUS stock value is trading based on other drugs in its pipeline and not muse. I got this feeling the market just does not value MUSE. Therefore maybe some patent news and drug trial advancements will be what drives the stock price.

Of course, just maybe, Muse still has some life in it. I believe it does.

Waiting for news from Germany.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News